A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
J Antimicrob Chemother
; 72(suppl_2): i48-i53, 2017 Sep 01.
Article
in En
| MEDLINE
| ID: mdl-28922809
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mycobacterium avium Complex
/
Mycobacterium avium-intracellulare Infection
/
Lung Diseases
/
Anti-Bacterial Agents
/
Models, Biological
Limits:
Humans
Language:
En
Journal:
J Antimicrob Chemother
Year:
2017
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom